
Chameli Das
Examiner (ID: 7327, Phone: (571)272-3696 , Office: P/2197 )
| Most Active Art Unit | 2197 |
| Art Unit(s) | 2197, 2196, 2762, 2122, 2192 |
| Total Applications | 1155 |
| Issued Applications | 1034 |
| Pending Applications | 35 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7801160
[patent_doc_number] => 08129432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor'
[patent_app_type] => utility
[patent_app_number] => 12/526311
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 21
[patent_no_of_words] => 7552
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526311 | Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor | Feb 14, 2008 | Issued |
Array
(
[id] => 4718648
[patent_doc_number] => 20080241170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells'
[patent_app_type] => utility
[patent_app_number] => 12/024897
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17873
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12024897
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/024897 | Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells | Jan 31, 2008 | Issued |
Array
(
[id] => 4532509
[patent_doc_number] => 07871784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins'
[patent_app_type] => utility
[patent_app_number] => 12/024715
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 28830
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12024715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/024715 | Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins | Jan 31, 2008 | Issued |
Array
(
[id] => 6143127
[patent_doc_number] => 20110129845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'METHOD OF DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/523506
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12253
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523506
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523506 | METHOD OF DIAGNOSIS | Jan 24, 2008 | Abandoned |
Array
(
[id] => 6577713
[patent_doc_number] => 20100047299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE'
[patent_app_type] => utility
[patent_app_number] => 12/524229
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11801
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524229 | USE OF GDF-5 FOR THE IMPROVEMENT OR MAINTENANCE OF DERMAL APPEARANCE | Jan 23, 2008 | Abandoned |
Array
(
[id] => 5491036
[patent_doc_number] => 20090292107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 12/018582
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 30258
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20090292107.pdf
[firstpage_image] =>[orig_patent_app_number] => 12018582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/018582 | COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECT | Jan 22, 2008 | Abandoned |
Array
(
[id] => 4813853
[patent_doc_number] => 20080194484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'TML polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 12/009230
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18568
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12009230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/009230 | TML polynucleotides | Jan 15, 2008 | Abandoned |
Array
(
[id] => 8749469
[patent_doc_number] => 08415302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Surgical applications for BMP binding protein'
[patent_app_type] => utility
[patent_app_number] => 12/448497
[patent_app_country] => US
[patent_app_date] => 2007-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 10852
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12448497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448497 | Surgical applications for BMP binding protein | Dec 25, 2007 | Issued |
Array
(
[id] => 8176219
[patent_doc_number] => 08178099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Methods of altering bone growth by administration of sost or wise antagonist or agonist'
[patent_app_type] => utility
[patent_app_number] => 11/962522
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9705
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178099.pdf
[firstpage_image] =>[orig_patent_app_number] => 11962522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/962522 | Methods of altering bone growth by administration of sost or wise antagonist or agonist | Dec 20, 2007 | Issued |
Array
(
[id] => 5271002
[patent_doc_number] => 20090074778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Connective Tissue Growth Factor (CTGF-3)'
[patent_app_type] => utility
[patent_app_number] => 11/962282
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20874
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074778.pdf
[firstpage_image] =>[orig_patent_app_number] => 11962282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/962282 | Connective tissue growth factor (CTGF-3) | Dec 20, 2007 | Issued |
Array
(
[id] => 6480684
[patent_doc_number] => 20100092558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Method for Producing a Product Having a Polymer Matrix, Implants Made Thereof and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/520527
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092558.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520527
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520527 | Method for producing a product having a polymer matrix, implants made thereof and use thereof | Dec 18, 2007 | Issued |
Array
(
[id] => 5992955
[patent_doc_number] => 20110014608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/520515
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17800
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12520515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520515 | Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases | Dec 18, 2007 | Issued |
Array
(
[id] => 6231397
[patent_doc_number] => 20100184659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents'
[patent_app_type] => utility
[patent_app_number] => 12/516922
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11539
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516922
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516922 | Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents | Dec 18, 2007 | Abandoned |
Array
(
[id] => 6513920
[patent_doc_number] => 20100216704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'NOVEL GENES AND PROTEINS THAT HOME TO DEVELOPING MICROVESSELS'
[patent_app_type] => utility
[patent_app_number] => 12/516961
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13358
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516961 | Genes and proteins that home to developing microvessels | Nov 29, 2007 | Issued |
Array
(
[id] => 8214601
[patent_doc_number] => 08193312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Bone morphogenic protein binding peptide'
[patent_app_type] => utility
[patent_app_number] => 11/985745
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 7448
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985745 | Bone morphogenic protein binding peptide | Nov 15, 2007 | Issued |
Array
(
[id] => 4682282
[patent_doc_number] => 20080248508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials'
[patent_app_type] => utility
[patent_app_number] => 11/985057
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9746
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248508.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985057 | Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials | Nov 12, 2007 | Abandoned |
Array
(
[id] => 6645912
[patent_doc_number] => 20100313281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'VARIANTS AND METHODS OF USING TRANSFORMING GROWTH FACTOR BETA-9'
[patent_app_type] => utility
[patent_app_number] => 12/514143
[patent_app_country] => US
[patent_app_date] => 2007-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20891
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20100313281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514143 | VARIANTS AND METHODS OF USING TRANSFORMING GROWTH FACTOR BETA-9 | Nov 7, 2007 | Abandoned |
Array
(
[id] => 4833363
[patent_doc_number] => 20080131910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use'
[patent_app_type] => utility
[patent_app_number] => 11/980023
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12358
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11980023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/980023 | Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5398278
[patent_doc_number] => 20090318341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Methods of using OSK1 peptide analogs'
[patent_app_type] => utility
[patent_app_number] => 11/978119
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 128
[patent_figures_cnt] => 128
[patent_no_of_words] => 109394
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978119 | Methods of using OSK1 peptide analogs | Oct 24, 2007 | Issued |
Array
(
[id] => 5316430
[patent_doc_number] => 20090281028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'OSK1 peptide analogs and pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/978110
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 128
[patent_figures_cnt] => 128
[patent_no_of_words] => 109417
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281028.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978110
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978110 | OSK1 peptide analogs and pharmaceutical compositions | Oct 24, 2007 | Issued |